Royal Bank of Canada’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228M | Sell |
|
|||||
|
2025
Q1 | $313M | Sell |
|
|||||
|
2024
Q4 | $267M | Buy |
|
|||||
|
2024
Q3 | $360M | Buy |
|
|||||
|
2024
Q2 | $337M | Buy |
|
|||||
|
2024
Q1 | $317M | Sell |
|
|||||
|
2023
Q4 | $326M | Buy |
|
|||||
|
2023
Q3 | $266M | Sell |
|
|||||
|
2023
Q2 | $333M | Buy |
|
|||||
|
2023
Q1 | $288M | Sell |
|
|||||
|
2022
Q4 | $519M | Buy |
|
|||||
|
2022
Q3 | $435M | Buy |
|
|||||
|
2022
Q2 | $449M | Buy |
|
|||||
|
2022
Q1 | $425M | Sell |
|
|||||
|
2021
Q4 | $421M | Buy |
|
|||||
|
2021
Q3 | $336M | Buy |
|
|||||
|
2021
Q2 | $318M | Sell |
|
|||||
|
2021
Q1 | $334M | Buy |
|
|||||
|
2020
Q4 | $249M | Sell |
|
|||||
|
2020
Q3 | $220M | Sell |
|
|||||
|
2020
Q2 | $247M | Sell |
|
|||||
|
2020
Q1 | $271M | Buy |
|
|||||
|
2019
Q4 | $253M | Buy |
|
|||||
|
2019
Q3 | $114M | Sell |
|
|||||
|
2019
Q2 | $191M | Sell |
|
|||||
|
2019
Q1 | $306M | Buy |
|
|||||
|
2018
Q4 | $247M | Sell |
|
|||||
|
2018
Q3 | $264M | Buy |
|
|||||
|
2018
Q2 | $200M | Sell |
|
|||||
|
2018
Q1 | $220M | Buy |
|
|||||
|
2017
Q4 | $165M | Buy |
|
|||||
|
2017
Q3 | $79M | Sell |
|
|||||
|
2017
Q2 | $79M | Buy |
|
|||||
|
2017
Q1 | $47.9M | Buy |
|
|||||
|
2016
Q4 | $24.6M | Sell |
|
|||||
|
2016
Q3 | $70.8M | Buy |
|
|||||
|
2016
Q2 | $45.6M | Buy |
|
|||||
|
2016
Q1 | $43.9M | Sell |
|
|||||
|
2015
Q4 | $98.2M | Sell |
|
|||||
|
2015
Q3 | $115M | Sell |
|
|||||
|
2015
Q2 | $207M | Buy |
|
|||||
|
2015
Q1 | $177M | Sell |
|
|||||
|
2014
Q4 | $159M | Sell |
|
|||||
|
2014
Q3 | $173M | Sell |
|
|||||
|
2014
Q2 | $165M | Buy |
|
|||||
|
2014
Q1 | $105M | Buy |
|
|||||
|
2013
Q4 | $68M | Buy |
|
|||||
|
2013
Q3 | $40.3M | Sell |
|
|||||
|
2013
Q2 | $39.8M | Buy |
|